
Elegen and Nutcracker Therapeutics Launch Pilot of First Fully Cell-Free Manufacturing Process for Personalized RNA Cancer Therapies
A global leader in next-generation DNA manufacturing, and Nutcracker Therapeutics, a global leader in next-generation RNA design and manufacturing, today announced the launch of a pilot program to demonstrate the industry’s first fully synthetic, cell-free manufacturing platform for RNA-based personalized cancer…












